Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Liu Hong, Ph.D
Xijing Hospital of Digestive Diseases, Xijing Hospital, Air force Medical University, Changlexi ST 15, Shaanxi Province, 710032, China
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Fourth Hospital of Hebei Medical University
Shijiazhuang, Heibei Province, China
Recruiting - Department of Digestive Surgery, Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi' An, China
Xi'an, Shaanxi, China
Recruiting - Department of General Surgery, Tangdu Hospital, Air Force Medical University
Xi'an, Shaanxi, China
Recruiting - Department of General Surgery, the 986th Military Hospital, Air Force Medical University
Xi'an, Shaanxi, China
Recruiting - Tianjin Medical University Cancer Institute & Hospital
Tianjin, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Nov 2024
- Primary completion
- 31 May 2026
- Completion
- 30 Sept 2026
- Last update posted
- 23 Apr 2026
- Registered enrollment
- 116
- Registry id
- NCT06576921
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.